Project Grant R01MH145188
- The National Institute of Mental Health awarded The Johns Hopkins University $737,756 on September 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a five-year study of mobile crisis services utilization, outcomes, and implementation across state Medicaid programs. The research will merge 2021–2025 Medicaid claims data with local workforce, socioeconomic, and policy files from nine states and the District of Columbia, paired with 45 stakeholder interviews....
- The National Institute of Mental Health awarded Miresource, Inc. $1.744 million on September 12, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop a longitudinal mental health monitoring platform that generates personalized care guides and treatment referrals. Miresource will integrate software solutions, curate mental health content, and employ artificial intelligence to create personalized guides and automate triage and referral recommendations. The project aims to...
- The National Institute of Mental Health awarded the University of California, Berkeley, $210,915 under the Mental Health Research Grants program (CFDA 93.242) on August 1, 2026. The award funds an 8-week remote summer workshop series that trains early-, mid-career, and senior-level social and behavioral scientists in machine learning and emerging artificial intelligence technologies, including generative AI and large language models. The curriculum begins with Python programming from a data...
- The National Institute of Mental Health awarded the University of California, San Diego $2.115 million on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate a mobile health system delivering just-in-time adaptive interventions based on dialectical behavior therapy principles for young adults with comorbid major depressive disorder, social anxiety disorder, generalized anxiety disorder, and related anxiety conditions. The UNDERSTAND project...
- The National Institute of Mental Health awarded the University of California, Berkeley $759,816 on May 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop targeted machine learning estimators for analyzing cluster randomized trials of HIV prevention strategies. The award funds methodological research addressing two critical gaps in cluster randomized trial (CRT) analysis. The first involves developing machine learning methods to minimize bias from missing data in...
- The National Institute of Mental Health awarded the University of California, San Diego $793,814 on June 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate Recovery Integrated Safety and Engagement (RISE), a peer-supported suicide prevention intervention for individuals at clinical high risk for psychosis. The award funds a three-year hybrid Type 1 pilot study at two sites following the Exploration, Preparation, Implementation, Sustainment framework....
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $410,000 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and test a single-session consultation protocol for treatment-seeking youth with eating disorders and their caregivers while waiting for specialty care access. The research follows a Type I hybrid effectiveness-implementation trial structure. UCSF will conduct a preparatory phase engaging...
- The National Institute of Mental Health awarded the University of California, San Diego $199,271 on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop a measurement-informed machine learning model for generalizable suicide risk prediction in youth. The project will create a transparent, interpretable, and developmentally sensitive machine learning model incorporating neurobiological, psychological, electronic health record-derived, and social indicators to...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $800,384 on March 10, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct molecular and functional dissection of prefrontal-hippocampal long-range inhibition. The project investigates a novel long-range GABAergic pathway from prefrontal cortex to hippocampus that mediates top-down control of hippocampal function. The research will elucidate mechanisms through...
- The National Institute of Mental Health awarded the University of California, Los Angeles $436,934 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a longitudinal study of suicidal thoughts and behaviors in Mexican-origin youth. The project tracks developmental trajectories of suicidal thoughts and behaviors from preadolescence through young adulthood in a cohort of 674 Mexican-origin youth, leveraging 19 years of existing data from the California...
The National Institute of Mental Health awarded the University of California, Berkeley $815,743 on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a rigorous evaluation of mobile crisis response services for suicide prevention. The award funds a quasi-experimental instrumental variables study and qualitative analysis of the A3 Crisis Response Program in Contra Costa County, California, which operates a 24/7 crisis call center and 30+ mobile crisis teams serving 1.2 million residents across 19 cities and 700 square miles. The research will establish the causal impact of in-person mobile crisis response versus telephone-only support on suicide and self-harm outcomes, and test whether increased engagement with community-based follow-up care (outpatient mental health, substance use disorder treatment, and primary care) mediates reductions in acute service use and jail intake. The study will also track service use outcomes including involuntary psychiatric holds, psychiatric emergency services, emergency department visits, inpatient hospitalizations, and outpatient treatment encounters. Work will be performed in Berkeley, California, with a period of performance through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $815.7k | 8/14/26 |